Colucci, Mattia
Trivieri, Nadia
Mencarelli, Gandino
De Santis, Elisabetta
Sansico, Francesca
Tamiro, Francesco
Visioli, Alberto
Barile, Chiara
Pracella, Riccardo
Rossi, Giovanni
Binda, Elena
Giambra, Vincenzo
Funding for this research was provided by:
Ministero della Salute (GR-2011-02351534, Progetto Ricerca Corrente 2020-2023)
Associazione Italiana per la Ricerca sul Cancro (IG-23070)
Worldwide Cancer Research (20-0318)
Article History
Received: 21 July 2023
Accepted: 5 October 2023
First Online: 20 October 2023
Declarations
:
: The cohort of human samples involved in this study were enrolled at “Fondazione IRCCS Casa Sollievo della Sofferenza” after approval of the institutional Ethic board <b>(</b>Prot. N.155/CE, ICF: V1.0_16 Mag 18). All the subject agreed to participate with signed informed consent and all human samples and data were collected and utilized according to the ethical guidelines of 2013 Declaration of Helsinki. Material was anonymized at the time of collection. The animal procedures were performed according to the Italian Regulation for Animal Health and Welfare after protocol approval by the Institutional Review Boards of the Italian Ministry of Health (509/2018-PR).
: Not applicable.
: Alberto Visioli is an employee of Stemgen Spa and does not own shares in the Company. The others authors declare that they have no competing interests.